RaDVaC Data Explorer
Antiviral database
Virus Taxonomy
← Back to Dashboard
Resveratrol
Multiple
2D Structure
Loading structure...
3D Structure
Loading 3D structure...
Chemical Identifiers
SMILES:
C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O
InChI Key:
LUKBXSAWLPMMSZ-OWOJBTEDSA-N
ClinicalTrials.gov
PubMed
Clinical Development by Virus
12
Influenza A virus
FLUAV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:15838800
Rotavirus
RoV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:32682225
Human gammaherpesvirus 4
EBV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:12162952
Human orthopneumovirus
RSV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:21937650
Zika virus
ZIKV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:34282543
Human betaherpesvirus 5
CMV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:15302137
Human alphaherpesvirus 1
HSV-1
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:10551373
Human alphaherpesvirus 2
HSV-2
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:10551373
Middle East respiratory syndrome-related coronavirus
MERS-CoV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:28193191
Severe acute respiratory syndrome-related coronavirus
SARS-CoV-2
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:33222316
Enterovirus A
EV-A71
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:25692777
African swine fever virus
ASFV
Target: Human multiple; Viral transcriptional regulator
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:21557969